2002
DOI: 10.1067/mob.2002.123544
|View full text |Cite
|
Sign up to set email alerts
|

Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
147
2
11

Year Published

2002
2002
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 247 publications
(189 citation statements)
references
References 23 publications
7
147
2
11
Order By: Relevance
“…Magnesium sulfate tocolysis has been associated with various neonatal morbidities and mortality. [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] The specific association of PIE with increased mortality in ELBW infants was not previously documented. Preterm labor is associated with elevated concentrations of fetal proinflammatory cytokines and other mediators.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Magnesium sulfate tocolysis has been associated with various neonatal morbidities and mortality. [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] The specific association of PIE with increased mortality in ELBW infants was not previously documented. Preterm labor is associated with elevated concentrations of fetal proinflammatory cytokines and other mediators.…”
Section: Discussionmentioning
confidence: 99%
“…27 The data regarding antenatal MgSO 4 and IVH is not entirely conclusive even though Mittendorf found a higher incidence of IVH with magnesium tocolysis in infants <34 weeks of gestation. 11 In a large study involving 1409 infants the relative risk of IVH with maternal receipt of MgSO 4 was 1 (CI 0.7-1.3). The multivariate analysis using a model that controlled the significant covariates yielded a strong Odds ratio for the dosespecific relationship between MgSO 4 and PIE in our study.…”
Section: Discussionmentioning
confidence: 99%
“…The trial was suspended after 15 months of enrollment because of excess pediatric mortality among those exposed to magnesium sulfate compared to those assigned to other tocolytics (AR ¼ 15.2, 95% CI ¼ 4.8 to 25.6). 5,6,17 A random-effects model meta-analysis combining data from this study with one by Cox et al 18 showed a statistically significant association between tocolytic magnesium and total pediatric death (AR ¼ 10.7, 95% CI ¼ 3.9 to 17.6). 2 In addition to these studies, others have demonstrated an association of magnesium exposure with adverse infant outcome.…”
Section: Discussionmentioning
confidence: 60%
“…In infants whose mothers were treated with magnesium sulfate, significantly elevated levels of magnesium have been measured in the infant's cord blood at delivery. 17 Hypermagnesemia is a well-known cause of neonatal lethargy, hypotonia, and respiratory depression. 5 This diminished respiratory drive could explain the increased risk for respiratory distress and need for endotracheal intubation seen in the tocolytic-exposed infants in our study.…”
Section: Discussionmentioning
confidence: 99%
“…4 Owing to the growing evidence suggestive of an association between LSV and two of these adverse outcomes, we are currently investigating whether magnesium sulfate (in the oftenextraordinary dosages used for tocolysis) may be associated with the LSV lesion as well.…”
Section: Dear Editormentioning
confidence: 99%